Soleno Therapeutics, Inc.
SLNO
$33.39
-$0.37-1.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.89M | -78.45M | -181.08M | -198.23M | -175.85M |
| Total Depreciation and Amortization | 2.02M | 2.01M | 2.01M | 2.00M | 1.99M |
| Total Amortization of Deferred Charges | 35.00K | 26.00K | 17.00K | 8.00K | -- |
| Total Other Non-Cash Items | 48.49M | 66.13M | 111.43M | 109.17M | 98.75M |
| Change in Net Operating Assets | -24.63M | -15.61M | -16.65M | -2.28M | 6.02M |
| Cash from Operations | 46.80M | -25.90M | -84.28M | -89.32M | -69.10M |
| Capital Expenditure | -73.00K | -23.00K | -213.00K | -212.00K | -218.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -201.71M | -69.96M | 25.72M | -87.29M | -225.46M |
| Cash from Investing | -201.78M | -69.98M | 25.51M | -87.50M | -225.68M |
| Total Debt Issued | -- | 49.89M | 49.89M | 49.89M | 49.89M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 238.11M | 244.33M | 28.63M | 165.48M | 163.14M |
| Repurchase of Common Stock | -100.89M | -33.00K | -33.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -62.00K | -62.00K | -240.00K | -62.00K | -- |
| Cash from Financing | 137.16M | 294.12M | 78.25M | 215.31M | 213.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.82M | 198.25M | 19.47M | 38.48M | -81.75M |